Initial experience with an intravenous P2Y12 platelet receptor antagonist in patients undergoing percutaneous coronary intervention: Results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial

Adam B. Greenbaum, Cindy L. Grines, John A. Bittl, Richard C. Becker, Dean J. Kereiakes, Ian C. Gilchrist, Jane Clegg, Jill E. Stankowski, Donna R. Grogan, Robert A. Harrington, Hakan Emanuelsson, W. Douglas Weaver

Research output: Contribution to journalArticlepeer-review

150 Scopus citations

Fingerprint Dive into the research topics of 'Initial experience with an intravenous P2Y<sub>12</sub> platelet receptor antagonist in patients undergoing percutaneous coronary intervention: Results from a 2-part, phase II, multicenter, randomized, placebo- and active-controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences